| Authors: |
Mercado-Gómez M; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Goikoetxea-Usandizaga N; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain.; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain., Giné AE; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Merlos Rodrigo MA; Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic., Afonso MB; The Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal., Azkargorta M; Proteomics Platform, Bizkaia Science and Technology Park, Derio, Spain., Zapata-Pavas LE; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Rejano-Gordillo CM; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Romero MR; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.; Experimental Hepatology and Drug Targeting (HEVEPHARM), IBSAL, University of Salamanca, Salamanca, Spain., Mendizabal I; Cancer Cell Signaling and Metabolism Lab, CIC bioGUNE, Basque Research And Technology Alliance (BRTA), Derio, Spain.; Ikerbasque Basque Foundation for Science, Bilbao, Spain., Rodrigues PM; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.; Ikerbasque Basque Foundation for Science, Bilbao, Spain.; Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Donostia-San Sebastian, Spain., Wu H; Immunology, Ophthalmology and ENT, Complutense University of Madrid Faculty of Medicine, Madrid, Comunidad de Madrid, Spain., Rodríguez-Agudo R; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Serrano-Maciá M; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Olaizola P; Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Donostia-San Sebastian, Spain., Barrenechea-Barrenechea JA; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., González Recio I; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., G Fernandez-Barrena M; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.; Hepatology Laboratory Solid Tumors Program CIMA CCUN IdiSNA, Pamplona, Navarra, Spain., Overi D; Department of Anatomical, Histological, Forensic Medicine and Orthopaedics Sciences, Sapienza University of Rome, Rome, Italy., Gaudio E; Department of Anatomical, Histological, Forensic Medicine and Orthopaedics Sciences, Sapienza University of Rome, Rome, Italy., Schaeper U; SilenceTherapeutics GmbH, Berlin, Germany., Garcia-Longarte S; Cancer Cell Signaling and Metabolism Lab, CIC bioGUNE, Basque Research And Technology Alliance (BRTA), Derio, Spain., Yáñez-Bartolomé M; Upper Gastrointestinal and Endocrine Tumor Unit, VHIO, Vall d'Hebron University Hospital, Barcelona, Spain.; Clinical Research, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Peña-SanFelix P; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Gil-Pitarch C; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Lapitz A; Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Donostia-San Sebastian, Spain., Michalkova H; Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic., Heger Z; Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic., Conter C; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Macias RIR; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.; Experimental Hepatology and Drug Targeting (HEVEPHARM), IBSAL, University of Salamanca, Salamanca, Spain., Carracedo A; Cancer Cell Signaling and Metabolism Lab, CIC bioGUNE, Basque Research And Technology Alliance (BRTA), Derio, Spain.; Ikerbasque Basque Foundation for Science, Bilbao, Spain., Bañales J; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.; Ikerbasque Basque Foundation for Science, Bilbao, Spain.; Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Donostia-San Sebastian, Spain.; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain., Moreno V; START Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Lamarca A; Medical Oncology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain, Madrid, Spain., Singh R; Department of Medicine, David Geffen School of Medicine, Los Angeles, California, USA.; Comprehensive Liver Research Center at University of California, Los Angeles, California, USA., Delgado TC; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Martínez-Cruz LA; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain., Elortza F; Proteomics Platform, CIC bioGUNE, ProteoRed-ISCIII, Bizkaia Science and Technology Park, Derio, Spain, CIC bioGUNE, Bizkaia, Spain., Avila MA; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.; Hepatology Laboratory Solid Tumors Program CIMA CCUN IdiSNA, Pamplona, Navarra, Spain., Martín C; Biochemistry and Molecular Biology, UPV/EHU, Leioa, Spain., Tian TV; Upper Gastrointestinal and Endocrine Tumor Unit, VHIO, Vall d'Hebron University Hospital, Barcelona, Spain.; Clinical Research, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Macarulla T; Upper Gastrointestinal and Endocrine Tumor Unit, VHIO, Vall d'Hebron University Hospital, Barcelona, Spain.; Clinical Research, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Buccella D; Department of Chemistry, New York University, New York, New York, USA., Cubero FJ; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.; Immunology, Ophthalmology and ENT, Complutense University of Madrid Faculty of Medicine, Madrid, Comunidad de Madrid, Spain., Calvisi DF; Institute of Pathology, University of Regensburg, Regensburg, Germany.; Medical, Surgical, and Clinical Sciences, University of Sassari, Sassari, Italy., Carpino G; Department of Anatomical, Histological, Forensic Medicine and Orthopaedics Sciences, Sapienza University of Rome, Rome, Italy., Marin JJG; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.; Experimental Hepatology and Drug Targeting (HEVEPHARM), IBSAL, University of Salamanca, Salamanca, Spain., Rodrigues CMP; The Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal., Martinez-Chantar ML; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain mlmartinez@cicbiogune.es.; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain. |
